Latest News for: avm gmbh

Edit

Burkitt Lymphoma Market Expected to Witness Significant Growth by 2032 | DelveInsight

GetNews 04 Apr 2025
B-cell Lymphoma Pipeline Insight provides comprehensive insights about the B-cell Lymphoma pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the ...
Edit

B-Cell Lymphoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 24 Mar 2025
The leading B-Cell Lymphoma Companies such as Lisocabtagene maraleucel, Hoffmann-La Roche, Nektar Therapeutics, Miltenyi Biomedicine GmbH, AVM Biotechnology, Lin BioScience, Inc., Incyte Corporation, ...
  • 1
×